Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Fitbit vs. hospital ECG: can a smartwatch save hearts?

NCT ID NCT06887387

First seen May 28, 2026 · Last updated Jun 19, 2026 · Updated 2 times

Summary

This study is testing whether a Fitbit can accurately measure heart electrical activity (QT interval) in 80 adults with Long QT Syndrome, a condition that can cause dangerous heart rhythms. Participants will use a Fitbit to take weekly ECG readings at home, which will be compared to standard hospital ECGs. The goal is to see if wearable devices can reliably track heart health and help explain symptoms, potentially reducing the need for frequent clinic visits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG QT SYNDROME are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Barts and London Hospital NHS Trust

    RECRUITING

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

The condition(s) this trial relates to.

long QT syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.